GlassScriptPhysician profile
Steven R Levine
NPI 1407827546
$54,878.21
in general payments reported to CMS, 2019-2025
11 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,425 · 2021: $38K · 2022: $8,156 · 2023: $1,844 · 2024: $4,701 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,701 · Travel and Lodging: $1,454 · Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,700.75 |
| Travel and Lodging | $1,453.92 |
| Food and Beverage | $532.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $36,203.18 | 2021 | |
| Novo Nordisk INC | $8,156.15 | 2022 | |
| Merck Healthcare Kgaa | $4,350.00 | 2024 | |
| Genentech, INC. | $2,319.85 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,844.14 | 2023 | |
| Ge Healthcare | $1,407.00 | 2021 | |
| Becton, Dickinson and Company | $350.75 | 2024 | |
| Abbvie INC. | $142.10 | 2025 | |
| Genentech USA, INC. | $80.25 | 2019 | |
| Medtronic USA, INC. | $24.79 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.